Atlantic Capital Bancshares Stock Forecast, Price & News

Atlantic Capital Bancshares (NASDAQ:ACBI) Frequently Asked Questions

Is Atlantic Capital Bancshares a buy right now?

6 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Atlantic Capital Bancshares in the last twelve months. There are currently 2 hold ratings and 4 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "buy" Atlantic Capital Bancshares stock.
View analyst ratings for Atlantic Capital Bancshares or view top-rated stocks.

What stocks does MarketBeat like better than Atlantic Capital Bancshares?

Wall Street analysts have given Atlantic Capital Bancshares a "Buy" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but Atlantic Capital Bancshares wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

Are investors shorting Atlantic Capital Bancshares?

Atlantic Capital Bancshares saw a increase in short interest during the month of August. As of August 31st, there was short interest totaling 515,300 shares, an increase of 25.6% from the August 15th total of 410,300 shares. Based on an average trading volume of 128,900 shares, the short-interest ratio is presently 4.0 days. Approximately 2.7% of the company's stock are short sold.
View Atlantic Capital Bancshares' Short Interest.

When is Atlantic Capital Bancshares' next earnings date?

Atlantic Capital Bancshares is scheduled to release its next quarterly earnings announcement on Thursday, October 28th 2021.
View our earnings forecast for Atlantic Capital Bancshares.

How were Atlantic Capital Bancshares' earnings last quarter?

Atlantic Capital Bancshares, Inc. (NASDAQ:ACBI) released its quarterly earnings data on Thursday, July, 22nd. The bank reported $0.58 earnings per share (EPS) for the quarter, topping the Thomson Reuters' consensus estimate of $0.52 by $0.06. The bank had revenue of $29.24 million for the quarter, compared to analysts' expectations of $28.23 million. Atlantic Capital Bancshares had a net margin of 38.08% and a trailing twelve-month return on equity of 12.75%.
View Atlantic Capital Bancshares' earnings history.

How has Atlantic Capital Bancshares' stock price been impacted by COVID-19 (Coronavirus)?

Atlantic Capital Bancshares' stock was trading at $14.59 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization (WHO). Since then, ACBI stock has increased by 79.0% and is now trading at $26.12.
View which stocks have been most impacted by COVID-19.

What price target have analysts set for ACBI?

6 analysts have issued 12 month price targets for Atlantic Capital Bancshares' stock. Their forecasts range from $24.16 to $28.00. On average, they expect Atlantic Capital Bancshares' share price to reach $25.85 in the next year. This suggests that the stock has a possible downside of 1.1%.
View analysts' price targets for Atlantic Capital Bancshares or view top-rated stocks among Wall Street analysts.

Who are Atlantic Capital Bancshares' key executives?

Atlantic Capital Bancshares' management team includes the following people:

• Douglas L. Williams, President, Chief Executive Officer & Director
• Mark E. Robertson, Chief Operating Officer & Executive Vice President
• Patrick Timothy Oakes, CFO, Secretary, Treasurer & Executive VP
• Robert R. Bugbee, Chief Credit Officer & Executive Vice President
• Gray G. Fleming, Chief Risk Officer & Executive Vice President

Who are some of Atlantic Capital Bancshares' key competitors?

Some companies that are related to Atlantic Capital Bancshares include Heartland Financial USA (HTLF), FB Financial (FBK), Renasant (RNST), Veritex (VBTX), Banner (BANR), Seacoast Banking Co. of Florida (SBCF), Eagle Bancorp (EGBN), Great Western Bancorp (GWB), Enterprise Financial Services (EFSC), Lakeland Financial (LKFN), Stock Yards Bancorp (SYBT), First Busey (BUSE), Customers Bancorp (CUBI), TriCo Bancshares (TCBK) and OFG Bancorp (OFG).
View all of ACBI's competitors.

What other stocks do shareholders of Atlantic Capital Bancshares own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Atlantic Capital Bancshares investors own include Intelsat (I), Fossil Group (FOSL), AMC Entertainment (AMC), Bank of America (BAC), China Unicom (Hong Kong) (CHU), First Data (FDC), Zynga (ZNGA), Associated British Foods (ABF), Apollo Global Management (APO) and Avadel Pharmaceuticals (AVDL).

What is Atlantic Capital Bancshares' stock symbol?

Atlantic Capital Bancshares trades on the NASDAQ under the ticker symbol "ACBI."

Who are Atlantic Capital Bancshares' major shareholders?

Atlantic Capital Bancshares' stock is owned by a number of institutional and retail investors. Top institutional investors include Price T Rowe Associates Inc. MD (13.90%), BlackRock Inc. (7.12%), Dimensional Fund Advisors LP (5.36%), Vanguard Group Inc. (4.98%), The Manufacturers Life Insurance Company (3.23%) and Renaissance Technologies LLC (2.26%). Company insiders that own Atlantic Capital Bancshares stock include David Eidson, Henchy R Enden, James H Graves, Richard A Jr Oglesby, Robert R Bugbee II, Shantella E Cooper and Walter M Deriso Jr.
View institutional ownership trends for Atlantic Capital Bancshares.

Which institutional investors are selling Atlantic Capital Bancshares stock?

ACBI stock was sold by a variety of institutional investors in the last quarter, including BlackRock Inc., Russell Investments Group Ltd., BHZ Capital Management LP, Comerica Bank, California Public Employees Retirement System, JPMorgan Chase & Co., Boston Partners, and Dimensional Fund Advisors LP. Company insiders that have sold Atlantic Capital Bancshares company stock in the last year include James H Graves, and Robert R Bugbee II.
View insider buying and selling activity for Atlantic Capital Bancshares or view top insider-selling stocks.

Which institutional investors are buying Atlantic Capital Bancshares stock?

ACBI stock was bought by a variety of institutional investors in the last quarter, including Putnam Investments LLC, Hillsdale Investment Management Inc., Millennium Management LLC, Goldman Sachs Group Inc., Parametric Portfolio Associates LLC, State Street Corp, Vanguard Group Inc., and Montag A & Associates Inc.. Company insiders that have bought Atlantic Capital Bancshares stock in the last two years include David Eidson, Henchy R Enden, Richard A Jr Oglesby, Shantella E Cooper, and Walter M Deriso Jr.
View insider buying and selling activity for Atlantic Capital Bancshares or or view top insider-buying stocks.

How do I buy shares of Atlantic Capital Bancshares?

Shares of ACBI can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Atlantic Capital Bancshares' stock price today?

One share of ACBI stock can currently be purchased for approximately $26.12.

How much money does Atlantic Capital Bancshares make?

Atlantic Capital Bancshares has a market capitalization of $530.31 million and generates $109.28 million in revenue each year. The bank earns $22.54 million in net income (profit) each year or $1.05 on an earnings per share basis.

How many employees does Atlantic Capital Bancshares have?

Atlantic Capital Bancshares employs 201 workers across the globe.

What is Atlantic Capital Bancshares' official website?

The official website for Atlantic Capital Bancshares is www.atlanticcapitalbank.com.

Where are Atlantic Capital Bancshares' headquarters?

Atlantic Capital Bancshares is headquartered at 945 EAST PACES FERRY ROAD NE SUITE 1600, ATLANTA GA, 30326.

How can I contact Atlantic Capital Bancshares?

Atlantic Capital Bancshares' mailing address is 945 EAST PACES FERRY ROAD NE SUITE 1600, ATLANTA GA, 30326. The bank can be reached via phone at (404) 995-6050.